Versant Capital Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.2K Buy
734
+6
+0.8% +$312 ﹤0.01% 1501
2026
Q1
$34.9K Sell
728
-22
-3% -$964 ﹤0.01% 1462
2025
Q4
$29K Sell
750
-1,836
-71% -$70K ﹤0.01% 1405
2025
Q3
$91.2K Buy
2,586
+2,058
+390% +$74.5K 0.01% 751
2025
Q2
$19K Buy
528
+47
+10% +$1.56K ﹤0.01% 1563
2025
Q1
$15K Buy
481
+361
+301% +$11.4K ﹤0.01% 1504
2024
Q4
$3.06K Sell
120
-754
-86% -$20K ﹤0.01% 1949
2024
Q3
$24.7K Sell
874
-189
-18% -$5.24K 0.01% 734
2024
Q2
$28K Buy
1,063
+1,043
+5,215% +$28.9K 0.01% 587
2024
Q1
$607 Hold
20
﹤0.01% 1654
2023
Q4
$562 Buy
20
+10
+100% +$275 ﹤0.01% 1653
2023
Q3
$271 Buy
+10
New +$297 ﹤0.01% 1811

Other funds holding RPRX